Skip to main content
. 2016 Oct 5;6:34215. doi: 10.1038/srep34215

Figure 6. LNP containing Tetravalent Dengue sub-unit vaccine in Non-Human Primates.

Figure 6

The immunization regime and dosing schedule for Rhesus macaques vaccinated using tetravalent Dengue vaccine (Tetra DEN-80E) is depicted (a). Group numbers, number of animals per group and the test formulation administered to each group is specified in Fig. 6b. Tetra DEN-80E vaccine contains 10 μg, 10 μg, 10 μg, 20 μg, corresponding to DEN1/DEN2/DEN3/DEN4 serotypes respectively. Sera from immunized Rhesus macaques with specified test agents were collected at 0 hrs, 4 hrs, 8 hrs, and 24 hrs post dosing. Individual sera from each group were assayed in duplicates using the Luminex platform. The average value of each cytokine/chemokine from immunized animals at 0 hr (prebleed) time point was used to calculate the fold change. The fold change at 4 hrs, 8 hrs, and 24 hrs of individual animals are based on the heatmap color code depicted in Fig. 6c.